KEYWORDS
Treatment Considerations, Combination Therapy, Drug Development, Biological Therapies, Monoclonal Antibody Therapy, Diseases, Myeloid Malignancies, Chronic Myeloid Malignancies, Research, MPN, Clinical Research, Clinical Trials, Study Population, Human, Adult